search
Back to results

A Prospective Trial of the Intelon BOSS(TM) System

Primary Purpose

Cornea, Lens Diseases

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Brillouin Spectroscopy via BOSS System
Sponsored by
Intelon Optics, Inc
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Cornea

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Age 18 years or older
  2. Availability, willingness and sufficient cognitive awareness to comply with the examination procedures and schedule
  3. Signed Written Informed Consent

Exclusion Criteria:

  1. No light perception or low vision rendering the subject unable to fixate to keep gaze still enough to acquire images
  2. Presence of corneal opacity
  3. Presence of cortical cataracts visible in an undilated pupil
  4. Any systemic disease or disorder which would prohibit image acquisition (e.g., Parkinson's Disease).

Sites / Locations

  • Vold Vision plc

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Imaging by BOSS System

Arm Description

Imaging by the BOSS System

Outcomes

Primary Outcome Measures

Analysis of variance in corneal and lens measurements to determine repeatability and reproducibility
A random effect model will be used to assess variation due to device/operator configuration

Secondary Outcome Measures

Full Information

First Posted
July 7, 2021
Last Updated
June 8, 2022
Sponsor
Intelon Optics, Inc
search

1. Study Identification

Unique Protocol Identification Number
NCT04969406
Brief Title
A Prospective Trial of the Intelon BOSS(TM) System
Official Title
A Prospective Trial Designed to Evaluate the Repeatability and Reproducibility of the Intelon BOSS(TM) System
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Terminated
Why Stopped
Enrollment Difficulty
Study Start Date
July 24, 2021 (Actual)
Primary Completion Date
December 10, 2021 (Actual)
Study Completion Date
December 10, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Intelon Optics, Inc

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
A prospective, open-label, single-site clinical trial designed to evaluate the repeatability and reproducibility of biomechanical imaging by the BOSS device. Subjects will undergo unilateral biomechanical mapping of the cornea and lens by three BOSS devices operated by three (3) different operators.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cornea, Lens Diseases

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
23 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Imaging by BOSS System
Arm Type
Experimental
Arm Description
Imaging by the BOSS System
Intervention Type
Other
Intervention Name(s)
Brillouin Spectroscopy via BOSS System
Intervention Description
Biomechanical Imaging of the Cornea and Lens
Primary Outcome Measure Information:
Title
Analysis of variance in corneal and lens measurements to determine repeatability and reproducibility
Description
A random effect model will be used to assess variation due to device/operator configuration
Time Frame
Evaluation Visit (within 30 days of the Screening Visit)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 18 years or older Availability, willingness and sufficient cognitive awareness to comply with the examination procedures and schedule Signed Written Informed Consent Exclusion Criteria: No light perception or low vision rendering the subject unable to fixate to keep gaze still enough to acquire images Presence of corneal opacity Presence of cortical cataracts visible in an undilated pupil Any systemic disease or disorder which would prohibit image acquisition (e.g., Parkinson's Disease).
Facility Information:
Facility Name
Vold Vision plc
City
Fayetteville
State/Province
Arkansas
ZIP/Postal Code
72704
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Prospective Trial of the Intelon BOSS(TM) System

We'll reach out to this number within 24 hrs